Development of a predictive model for urgency urinary incontinence

Contemp Clin Trials. 2016 Nov:51:44-49. doi: 10.1016/j.cct.2016.09.005. Epub 2016 Sep 27.

Abstract

The ability to set realistic expectations of treatment response in patients with overactive bladder (OAB) can have an impact on patient engagement and adherence to study medication. In order to help set treatment expectations for OAB, a Physician Predictive Tool has been developed based on predictive modelling. Models have been developed utilizing data from eight Phase 3 and 4 fesoterodine clinical trials and these models enable the prediction of individual treatment response in subjects with OAB, based on various baseline characteristics. The data utilized and covariates that were hypothesized to influence treatment response are described. The model selection and development process are also outlined, and the final model and some example results utilizing this model are presented. Finally, we discuss the potential benefits and limitations of such a predictive tool.

Keywords: Fesoterodine; Overactive bladder; Predictive model; Treatment response; Urinary urgency incontinence.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Benzhydryl Compounds / therapeutic use*
  • Clinical Trials, Phase III as Topic
  • Clinical Trials, Phase IV as Topic
  • Humans
  • Muscarinic Antagonists / therapeutic use*
  • Risk Assessment
  • Treatment Outcome
  • Urinary Bladder, Overactive / complications
  • Urinary Bladder, Overactive / drug therapy*
  • Urinary Bladder, Overactive / physiopathology
  • Urinary Incontinence, Urge / etiology
  • Urinary Incontinence, Urge / physiopathology*

Substances

  • Benzhydryl Compounds
  • Muscarinic Antagonists
  • fesoterodine